CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).

被引：0
|
作者：
Li, Roger
Steinberg, Gary D.
Uchio, Edward M.
Lamm, Donald L.
Shah, Paras
Kamat, Ashish M.
Bivalacqua, Trinity
Packiam, Vignesh T.
Chisamore, Michael Jon
McAdory, John
Grandi, Paola
Hnat, Nataliya
Burke, James
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL USA
[2] Univ Chicago Med, Dept Surg, Chicago, IL USA
[3] Univ Calif Orange, Irvine Med Ctr, Orange, CA USA
[4] BCG Onc, Phoenix, AZ USA
[5] Mayo Clin, Rochester, MN USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[7] Johns Hopkins Univ Hosp, Baltimore, MD USA
[8] Univ Iowa, Dept Urol, Iowa City, IA USA
[9] Merck Co & Inc, Kenilworth, NJ USA
[10] CG Oncol, Irvine, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4597
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NONMUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward
    Lamm, Donald
    Paras, Shah
    Kamat, Ashish
    Bivalacqua, Trinity
    Packiam, Vignesh
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A696 - A696
  • [2] CORE1: Phase 2, Single Arm Study of CG0070 Combined with Pembrolizumab in Patients with Non Muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG)
    Steinberg, Gary D.
    Li, Roger
    Lamm, Donald
    Uchio, Edward
    Packiam, Vignesh
    Kamat, Ashish
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    [J]. MOLECULAR THERAPY, 2021, 29 (04) : 319 - 319
  • [3] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed
    Packiam, Vignesh
    Kamat, Ashish
    Chisamore, Michael
    McAdory, John
    Grandi, Paola
    Kim, Jee-Hyun
    Burke, James
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A1005 - A1005
  • [4] CORE1: PHASE 2, SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Uchio, Ed M.
    Shah, Paras
    Kamat, Ashish M.
    Hnat, Nataliya
    Chisamore, Michael J.
    Grandi, Paola
    Burke, James
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E927 - E927
  • [5] A phase 3, single-arm study of CG0070 in subjects with nonmuscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Edward M.
    Lamm, Donald L.
    Shore, Neal D.
    Kamat, Ashish M.
    Tyson, Mark
    Tran, Ben
    Anderson, Paul
    Grandi, Paola
    Burke, James M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [6] CORE1: Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Rixe, Olivier
    Castonguay, Vincent
    Conter, Henry
    Chalas, Eva
    Desai, Pratibha
    Squillante, Christian
    MacDonald, Lisa A.
    Conlon, Rebekah
    Bramhecha, Yogesh
    Hirsch, Heather
    Graff, Jeremy R.
    Fiset, Stephan
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [7] CORE1: PHASE 2 SINGLE ARM STUDY OF CG0070 COMBINED WITH PEMBROLIZUMAB IN PATIENTS WITH NON MUSCLE INVASIVE BLADDER CANCER UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Li, Roger
    Steinberg, Gary
    Uchio, Edward M.
    Lamm, Donald
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity J.
    Packiam, Vignesh
    Chisamore, Michael J.
    Mcadory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL OF UROLOGY, 2023, 209 : E408 - E409
  • [8] CORE1: Phase 2 single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Steinberg, G. S.
    Uchio, E. U.
    Lamm, D. L.
    Shah, P. S.
    Kamat, A. K.
    Trinity, B.
    Packiam, V.
    Chisamore, M. C.
    Mcadory, J.
    Grandi, P.
    Hnat, N.
    Burke, J.
    [J]. EUROPEAN UROLOGY, 2023, 83 : S603 - S603
  • [9] A phase 3, single-arm study of CG0070 in subjects with non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG).
    Uchio, Ed
    Lamm, Donald
    Shore, Neil
    Bivalacqua, Trinity
    Kamat, Ashish
    Tyson, Mark
    Anderson, Paul
    Grandi, Paola
    Burke, James
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [10] A PHASE 3, SINGLE-ARM STUDY OF CG0070 IN SUBJECTS WITH NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) UNRESPONSIVE TO BACILLUS CALMETTE-GUERIN (BCG)
    Uchio, Ed
    Lamm, Donald
    Shore, Neal
    Anderson, Paul
    Ben, Tran
    Kamat, Ashish
    McAdory, John
    Keel, Melody
    Grandi, Paola
    Burke, James
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A456 - A456
12345